We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
-4.84%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$22.8B
AUM Growth
-$2.73B
Cap. Flow
-$198M
Cap. Flow %
-0.87%
Top 10 Hldgs %
56.18%
Holding
523
New
63
Increased
107
Reduced
260
Closed
79

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$241M
2
TLN
Talen Energy Corp
TLN
+$218M
3
SPOT icon
Spotify
SPOT
+$183M
4
VST icon
Vistra
VST
+$130M
5
META icon
Meta Platforms (Facebook)
META
+$121M

Sector Composition

Rank Sector Weight
1 Technology 38.96%
2 Communication Services 18.14%
3 Consumer Discretionary 12.78%
4 Healthcare 10.98%
5 Industrials 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNGX icon
276
Tango Therapeutics
TNGX
$4.34B
$3.14M 0.01%
+150,070
New +$2.09M
SPSC icon
277
SPS Commerce
SPSC
$2.25B
$3.11M 0.01%
55,834
-44,203
-44% -$3.19M
AX icon
278
Axos Financial
AX
$5.45B
$3.05M 0.01%
35,888
-18,753
-34% -$1.71M
CDNA icon
279
CareDx
CDNA
$1.92B
$3M 0.01%
173,013
-1,735
-1% -$32.8K
SYRE icon
280
Spyre Therapeutics
SYRE
$8.87B
$3M 0.01%
+59,453
New +$2.24M
PEN icon
281
Penumbra
PEN
$12.5B
$2.98M 0.01%
9,088
-1,887
-17% -$639K
TMDX icon
282
Transmedics
TMDX
$2.5B
$2.98M 0.01%
30,005
-264
-0.9% -$34.4K
RBLX icon
283
Roblox
RBLX
$34B
$2.97M 0.01%
52,425
-246,689
-82% -$16.6M
CRWD icon
284
CrowdStrike
CRWD
$187B
$2.91M 0.01%
29,824
-11,748
-28% -$1.24M
INMD icon
285
InMode
INMD
$872M
$2.9M 0.01%
211,710
-158,781
-43% -$2.26M
SYY icon
286
Sysco
SYY
$39.7B
$2.89M 0.01%
40,466
-27
-0.1% -$2.23K
ADI icon
287
Analog Devices
ADI
$181B
$2.8M 0.01%
+8,803
New +$2.8M
LULU icon
288
lululemon athletica
LULU
$13B
$2.76M 0.01%
18,035
-99,788
-85% -$17.9M
UTHR icon
289
United Therapeutics
UTHR
$26.3B
$2.68M 0.01%
4,522
+2,431
+116% +$1.21M
PVLA
290
Palvella Therapeutics
PVLA
$1.98B
$2.65M 0.01%
21,236
-128,790
-86% -$13.4M
LITE icon
291
Lumentum
LITE
$59.4B
$2.58M 0.01%
+3,674
New +$2.02M
TVTX icon
292
Travere Therapeutics
TVTX
$5.33B
$2.56M 0.01%
86,236
-8,596
-9% -$257K
CRH icon
293
CRH
CRH
$66.7B
$2.56M 0.01%
24,370
-33,707
-58% -$3.96M
TERN
294
DELISTED
Terns Pharmaceuticals
TERN
$2.49M 0.01%
47,151
-42,721
-48% -$1.75M
TEVA icon
295
Teva Pharmaceuticals
TEVA
$35.9B
$2.47M 0.01%
81,865
-7,690
-9% -$247K
DSGX icon
296
Descartes Systems
DSGX
$5.84B
$2.45M 0.01%
34,289
+15,132
+79% +$1.12M
MSGS icon
297
Madison Square Garden
MSGS
$9.54B
$2.44M 0.01%
+7,601
New +$2.27M
WAT icon
298
Waters Corp
WAT
$36.8B
$2.43M 0.01%
8,171
-5,456
-40% -$1.87M
LHX icon
299
L3Harris
LHX
$55.9B
$2.41M 0.01%
+6,986
New +$2.44M
CTVA icon
300
Corteva
CTVA
$59.7B
$2.39M 0.01%
+28,506
New +$2.15M

Similar funds

Fred Alger Management's Q1 2026 Portfolio in Review

As of Q1 2026, Fred Alger Management held 523 positions worth $22.8B, down 11% from $25.5B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Fred Alger Management's Q1 2026 filing shows 63 new, 107 increased, 260 reduced and 79 closed positions. Its largest new stake was Arista Networks: 682,773 shares worth $83.8M. The largest sale was Applovin, an estimated $241M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 37% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Fred Alger Management's largest Q1 2026 buy was Arista Networks: 682,773 shares worth $83.8M.
  • Fred Alger Management added most to NVIDIA in Q1 2026, an estimated $198M increase.
  • Fred Alger Management's biggest Q1 2026 reduction was Applovin, cutting an estimated $241M.
  • Fred Alger Management fully exited Builders FirstSource in Q1 2026, selling an estimated $38.7M.
  • Fred Alger Management's ten largest holdings make up 56% of its $22.8B portfolio in Q1 2026.
  • Fred Alger Management opened 63 new positions and closed 79 in Q1 2026.
  • Fred Alger Management's portfolio value fell 11% quarter-over-quarter to $22.8B.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.